Isoray, Inc. Intellectual Property Contracts & Agreements
12 Contracts & Agreements
- License Agreements (12 contracts)
- License Agreement, by and between Perspective Therapeutics, Inc. and Mayo Foundation for Medical Education and Research, dated December 31, 2023 (Filed With SEC on March 28, 2024)
- Know-How License Agreement between Viewpoint Molecular Targeting, Inc. and Mayo Foundation For Medical Education and Research, dated February 22. 2022 (Filed With SEC on May 15, 2023)
- Amendment #4 to the Exclusive License Agreement between Viewpoint Molecular Targeting, Inc. and the University of Iowa Research Foundation, dated Jund 11, 2020 (Filed With SEC on May 15, 2023)
- Amendment #3 to the Exclusive License Agreement between Viewpoint Molecular Targeting, Inc. and the University of Iowa Research Foundation, dated January 30, 2020 (Filed With SEC on May 15, 2023)
- Amendment #2 to the Exclusive License Agreement between Viewpoint Molecular Targeting, Inc. and the University of Iowa Research Foundation, dated November 13, 2019 (Filed With SEC on May 15, 2023)
- Amendment #1 to the Exclusive License Agreement between Viewpoint Molecular Targeting, Inc. and the University of Iowa Research Foundation, dated July 31, 2018 (Filed With SEC on May 15, 2023)
- Exclusive License Agreement between Viewpoint Molecular Targeting, Inc. and the University of Iowa Research Foundation, dated June 5, 2018 (Filed With SEC on May 15, 2023)
- LICENSE AGREEMENT (Filed With SEC on August 19, 2011)
- LICENSE AGREEMENT (Filed With SEC on June 7, 2011)
- AMENDMENTNo. 1 dated as of October 12, 2007 to an existing LICENSE AGREEMENT (dated 2 February 2006) _____________________________ (Filed With SEC on October 17, 2007)
- LICENSE AGREEMENT between IBt SA and IsoRay Medical Inc. (Filed With SEC on May 2, 2006)
- LICENSE AGREEMENT between IBt SA and IsoRay Medical Inc. LICENSE AGREEMENT (Filed With SEC on March 24, 2006)
